Abbott (NYSE:ABT) is facing an investor suit from an Alaskan union-benefits fund over allegations that St. Jude Medical, which it closed its acquisition of in January, failed to notify regulators about defective lithium batteries in its implantable defibrillators. In the lawsuit, plaintiffs allege that St. Jude was informed of the battery defect “as early as 2011”, […]
Feds charge ex-Cleveland Clinic biz dev guru Fingerhut in $2.7m fraud scheme
Federal prosecutors in Ohio last week charged the former director of Cleveland Clinic Innovations, Gary Fingerhut, of participating in a $2.7 million fraud scheme. Fingerhut was fired in 2015 after the FBI contacted the clinic of financial transactions that violated the hospital system’s internal policies. Cleveland Clinic Innovations is the commercialization arm of the clinic, created to […]
Retractable Tech to appeal verdict in BD false advertising case
Retractable Technologies (NYSE:RVP) said late last week it is looking to appeal a decision in a false advertising case against Becton Dickinson & Co. (NYSE:BDX) after a judge last month ruled in BD’s favor. The company said it also filed a motion to alter or amend the judgement which ordered that the company take nothing in its […]
MiMedx loses appeal in placental allograft tissue patent spat
A Federal Circuit Court this week affirmed a Patent Trial and Appeal Board ruling which found a MiMedx (NSDQ:MDXG) tissue graft patent invalid in a spat between the company and the Musculoskeletal Transplant Foundation. The ruling came from a 3-judge panel, delivered in a 1-line order without an opinion, affirming the PTAB’s decision from last month […]
Judge: Firms must have permanent, physical presence in Delaware to file patent suits there
The District of Delaware Chief Judge said this week that businesses must have permanent residences in the state to be sued for patent infringement within it, following a series of US Supreme Court rulings, and transferred a patent spat case to Indiana. Chief Judge Leonard Stark said the precedent was set after the Supreme Court’s […]
Appeals court shoots down Synthes bid to unseal grand jury records in Norian bone cement trial
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes lost its bid to have some rand jury records unsealed for a wrongful death lawsuit brought over its Norian bone cements. At least 5 patients died during otherwise routine operations after the Norian cement was used off-label in their spine surgeries. The bone cement was initially developed by a company called […]
J&J’s Ethicon hit with $57m verdict in pelvic mesh case
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon has been hit with a $57.1 million verdict in a pelvic mesh case out of Pennsylvania, according to a report from The Inquirer. A jury in Philadelphia ordered the subsidiary to pay the damages to a woman who was left chronically incontinent and with chronic pain after being implanted with […]
Impax settles ‘fax-blasting’ class action suit over EpiPen alternative
Impax Laboratories (NSDQ:IPXL) will pony up $4.8 million to settle claims that it sent blasts of unsolicited faxes to Family Medicine Pharmacy advertising its epinephrine auto-injector, according to a document filed in a Alabama federal court this week. The Alabama-based pharmacy filed the proposed class action suit against Impax in January, alleging that the pharmaceutical company […]
Texas Judge delays J&J Pinnacle hip implant bellwether trial
A federal judge in Dallas has delayed a Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics Pinnacle hip implant bellwether trial until later this month, according to a Texas Lawyer report. The delay came after 2 of 3 judges on a Fifth Circuit Court panel refused a petition to halt the trail, but concluded that the judge had […]
Ex-broker pleads not guilty in insider trading case involving Abbott, St. Jude merger
A Morgan Stanley broker pleaded not guilty to charges that he engaged in insider trading in deals including Abbott‘s (NYSE:ABT) $25 billion acquisition of St. Jude Medical, according to an Investment News report. Defendant Michael Siva entered a plea on Tuesday in New York, with a 3-week trial slated to begin Sept. 2018. Siva was allegedly involved […]
Boston Scientific wins FCA whistleblower suit over Cognis CRT-Ds, Teligen ICDs
Boston Scientific (NYSE:BSX) has prevailed in dismissing a whistleblower suit alleging its sales of the Cognis cardiac resynchronization therapy defibrillators and Teligen implantable cardioverter defibrillators between 2008 and 2009 violated various false claims acts, according to court documents released late last week. In the suit, Boston Scientific was accused of defrauding the FDA by not reporting […]
- 1
- 2
- 3
- …
- 211
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+